1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Injury, Ischemia-Reperfusion in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.92) | 18.7374 |
1990's | 65 (63.73) | 18.2507 |
2000's | 29 (28.43) | 29.6817 |
2010's | 4 (3.92) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Cao, ZY; Luo, YP; Wang, ZZ; Xiao, W; Zhang, H; Zhang, XZ | 1 |
Bessi, VL; Bitencourt, CS; Borgeat, P; Faccioli, LH; Hamdan, L; Huynh, DN; Lefebvre, JS; Lévesque, T; Marleau, S; Ménard, L; Sohouhenou, F | 1 |
Beuk, RJ; Heineman, E; Maassen, RL; Oude Egbrink, MG; Quaedackers, JS; Tangelder, GJ | 1 |
Fangjie, Z; Guanghua, F; Jie, N; Meili, M; Xinmei, H; Xiping, Z; Yan, P | 1 |
Liu, SH; Ma, K; Xu, B; Xu, XR | 1 |
Cheung, LY; Childs, EW; Hunter, FA; Smalley, DM; Udobi, KF; Wood, JG | 1 |
Hara, M; Ishida, S; Korthuis, RJ; Sakata, T; Shigematsu, S; Takahashi, N; Yoshimatsu, H | 1 |
Fujimoto, K; Fujise, T; Iwakiri, R; Ootani, A; Tsunada, S; Wu, B | 1 |
Ishii, S; Pinho, V; Shimizu, T; Soares, AC; Souza, DG; Teixeira, MM | 1 |
Andersson, R; Börjesson, A; Olanders, K; Sun, ZW | 1 |
Caty, MG; Fung, HL; Khanna, A; Rossman, J | 1 |
Dammenhayn, L; Haverich, A; Hirt, SW; Jurmann, M; Rohde, R; Wahlers, T | 1 |
Koizumi, T; Kubo, K; Kurata, Y; Ogura, T; Ruan, Z; Shibamoto, T; Shimo, T; Tsuchida, H | 1 |
Souza, DG; Teixeira, MM | 1 |
Ahya, VN; Ardehali, A; Guenther, G; Keshavjee, S; Shargall, Y; Singhal, A | 1 |
Ozturk, H; Yagmur, Y | 1 |
Neerhof, MG; Thaete, LG | 1 |
Karidis, NP; Kouraklis, G; Theocharis, SE | 1 |
Andreadou, I; Arkadopoulos, N; Avgerinos, E; Costopanagiotou, C; Diamantopoulou, K; Kostopanagiotou, G; Lekka, M; Nakos, G; Smyrniotis, V | 1 |
Buurman, WA; Daemen, JH; Kootstra, G; Kurvers, HA; Tangelder, GJ; Tiebosch, AT; Yin, M | 1 |
Bremer, C; Lang, H; Oldhafer, KJ; Pichlmayr, R; Schüttler, W; Spiegel, HU | 1 |
Fukumura, D; Ishii, H; Kimura, H; Kurose, I; Miura, S; Morishita, T; Nagata, H; Suzuki, M; Tsuchiya, M | 1 |
Palmer, C | 1 |
Albert, DH; Summers, JB | 1 |
Adams, JG; Dhar, A; Shukla, SD; Silver, D | 1 |
Feuerstein, GZ; Hallenbeck, JM; Lindsberg, PJ; Sirén, AL | 1 |
Bel-Haouari, M; Boudjema, K; Chenard, MP; Cinqualbre, J; Doghmi, M; Jaeck, D; Takada, Y; Wolf, P | 1 |
Isselhard, W; Minor, T; Yamaguchi, T | 1 |
Ide, S; Kawahara, K; Nagayasu, T; Sasaki, N; Shingu, H; Tagawa, T; Takahashi, T; Tomita, M; Yamamoto, S | 1 |
Boudjema, K; Chenard, MP; Cinqualbre, J; Jaeck, D; Takada, Y; Wolf, P; Yamaoka, Y | 1 |
Booster, MH; Buurman, WA; Daemen, JH; Kondracki, S; Kootstra, G; Kurvers, HA; Tangelder, GJ; Yin, M | 1 |
Altavilla, D; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Sardella, A; Squadrito, F; Squadrito, G; Urna, G; Zingarelli, B | 1 |
Kimura, J; Namura, Y; Shio, H | 1 |
Mariscalco, MM | 1 |
Suzuki, S; Toledo-Pereyra, LH | 1 |
Hashikura, Y; Ikegami, T; Kawasaki, S; Makuuchi, M; Matsunami, H | 1 |
Calne, R; Chávez-Cartaya, RE; Jamieson, NV; Metcalfe, S; Ramirez-Romero, P | 1 |
Isselhard, W; Minor, T | 1 |
Altavilla, D; Bussolino, F; Calapai, G; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Saitta, A; Squadrito, F; Zingarelli, B | 1 |
Badosa, F; Bulbena, O; Closa, D; Fernández-Cruz, L; Gelpi, E; Hotter, G; Morris, M; Pi, F; Roselló-Catafau, J | 1 |
Alsina, J; Bordalba, JR; Carrera, M; Griño, JM; Martinez-Castelao, A; Moliner, R; Seron, D; Torras, J; Valles, J | 1 |
Borobia, FG; Escriba, JM; Fabregat, J; Farran, L; Figueras, J; Jaurrieta, E; Rafecas, A; Torras, J | 1 |
Baroggi, N; Braquet, P; Defaux, JP; Etienne, A; Thonier, F | 1 |
Inui, K | 1 |
Baba, S; Nakamura, S; Nishiyama, R; Suzuki, S | 1 |
Akamine, S; Kawahara, K; Muraoka, S; Nakamura, A; Tagawa, T; Takahashi, T; Tomita, M; Yamamoto, S | 1 |
Carter, MB; Garrison, RN; Wead, WB; Wilson, MA | 1 |
Buurman, WA; Daemen, JW; Kootstra, G; Yin, M | 1 |
Baba, S; Nakamura, S; Nakano, M; Serizawa, A | 1 |
Biffl, WL; Moore, EE | 1 |
Ando, H; Kobayashi, K; Nakatani, T; Sakamoto, Y | 1 |
Durán, WN; Hobson, RW; Milazzo, VJ; Sabido, F | 1 |
Grinyó, JM; Torras, J; Valles, J | 1 |
Barks, JD; Eun, BL; Liu, XH; Silverstein, FS | 1 |
Durán, WN; Hobson, RW; Noel, AA | 1 |
Alsina, J; Cruzado, JM; Grinyo, JM; Herrero, I; Paubert-Braquet, M; Riera, M; Torras, J; Valles, J | 1 |
Arnold, F; Cherry, GW; He, CF | 1 |
Francescangeli, E; Freysz, L; Goracci, G | 1 |
Adams, JG; Dhar, A; Shukla, S; Silver, D; Slocum, M | 1 |
Kerrigan, CL; Stotland, MA | 1 |
Bzeizi, KI; Hayes, PC; Jalan, R; Plevris, JN | 1 |
Friedman, E; Shi, LC; Wang, HY | 1 |
Alataş, O; Colak, O; Inal, M; Kiper, H; Sahin, A; Yaşar, B | 1 |
Auchampach, JA; Cavero, I; Gross, GJ; Pieper, GM | 1 |
Jean, WC; Low, WC; Nussbaum, ES; Spellman, SR | 1 |
Birk-Sørensen, L; Kerrigan, CL; Wang, C | 1 |
Andersson, R; Börjesson, A; Haraldsen, P; Lasson, A; Leveau, P; Sun, Z; Wang, X | 1 |
Carboni, GL; Hillinger, S; Schmid, RA; Schneiter, D; Stammberger, U; Weder, W | 1 |
Timlioglu, O; Uluoglu, C | 1 |
Condom, E; Cruzado, JM; Duque, N; Egido, J; Espinosa, L; Grinyó, JM; Herrero, I; Lloberas, N; Merlos, M; Riera, M; Torras, J | 1 |
Al-Harbi, SA; Bak, I; Blasig, IE; Ferdinandy, P; Haines, DD; Mahmoud, FF; Tosaki, A | 1 |
Keown, PA; Nikbakht-Sangari, M; Qayumi, AK | 1 |
Bulkley, GB; Patel, M; Takada, T; Takano, M; Tien, N; Yamakawa, Y | 1 |
Andersson, R; Börjesson, A; Deng, X; Lasson, A; Soltesz, V; Sun, Z; Wang, X | 1 |
Anderson, GL; Guo, SZ; Miller, FN; Tsai, TM; Wang, WZ | 1 |
Baba, S; Fujise, Y; Kojima, Y; Konno, H; Kurachi, K; Nakamura, S; Okamoto, K; Sakaguchi, T; Serizawa, A; Suzuki, S; Tsuchiya, Y | 1 |
Baker, CJ; Barr, ML; Darbinian, SH; Kim, JD; Marcus, KA; Quardt, SM; Roberts, RF; Starnes, VA | 1 |
Alloatti, G; Camussi, G; Montrucchio, G | 1 |
Kelly, RF | 1 |
Alsina, J; Condom, E; Cruzado, JM; Grinyó, JM; Herrero-Fresneda, I; Lloberas, N; Merlos, M; Riera, M; Torras, J | 1 |
Balogh, I; Kecskeméti, V | 1 |
Andersson, R; Annborn, M; Böjesson, A; Lasson, A; Sun, Z; Wang, X | 1 |
Franke, U; Grote, M; Oppelt, P; Schaefers, HJ; Wahlers, T; Wittwer, T | 1 |
Li, ZJ; Wang, LH; Xin, H; Yan, GT | 1 |
Cruzado, JM; Grinyó, JM; Herrero, I; Lloberas, N; Riera, M; Torras, J | 1 |
Andersson, R; Börjesson, A; Inghammar, M; Sun, Z; Truedsson, L; Wang, X | 1 |
Anderson, DC; Dreyer, WJ; Entman, ML; Michael, LH; Nguyen, T; Rossen, RD; Smith, CW | 1 |
Levine, BA; McCollum, MO; Olson, MS; Zhou, W | 1 |
Kondo, M; Naito, Y; Takahashi, S; Tanigawa, T; Ueda, S; Yoshida, N; Yoshikawa, T | 1 |
Analouei, AR; Corcoran, PC; Foegh, ML; Katz, NM; Rajan, SS; Wallace, RB; Wang, Y | 1 |
Feuerstein, G; Rabinovici, R; Yue, TL | 1 |
Braquet, P; Filep, JG; Mózes, T | 1 |
Braquet, P; Drouet, Y; Droy-Lefaix, MT; Geraud, G; Hosford, D | 1 |
Itoh, M; Takeuchi, T | 1 |
Kondo, M; Naito, Y; Oyamada, H; Sugino, S; Takemura, T; Ueda, S; Yoshida, N; Yoshikawa, T | 1 |
Imai, S; Itoh, M; Iwai, A; Katoh, N; Kawai, T; Matsuba, S; Matsusako, K; Okayama, N; Yasue, N; Yokoyama, Y | 1 |
Braquet, P; Drouet, Y; Droy-Lefaix, MT; Géraud, G | 2 |
Binnaka, T; Hirohara, J; Kubota, Y; Mizuno, T; Sameshima, Y; Yamaguchi, T | 1 |
Endoh, K; Itoh, M; Iwai, A; Joh, T; Kawai, T; Matsusako, K; Miyamoto, T; Takeuchi, T; Yasue, N; Yokoyama, Y | 1 |
Braquet, P; Hosford, D; Koltai, M; Tosaki, A | 1 |
Makowka, L; Mazzaferro, V; Ontell, SJ; Ove, P; Starzl, TE; Trager, J | 1 |
12 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Injury, Ischemia-Reperfusion
Article | Year |
---|---|
Platelet-activating factor in liver injury: a relational scope.
Topics: Acute Disease; Chronic Disease; Hepatocytes; Humans; Liver; Liver Transplantation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reperfusion Injury | 2006 |
Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals.
Topics: Animals; Antioxidants; Asphyxia Neonatorum; Brain; Brain Damage, Chronic; Brain Ischemia; Cats; Cerebrovascular Circulation; Free Radicals; Humans; Hypoxia, Brain; Infant, Newborn; Microcirculation; Neutrophils; Platelet Activating Factor; Rats; Reperfusion Injury | 1995 |
Platelet activating factor antagonists.
Topics: Animals; Asthma; Humans; Ischemia; Models, Biological; Pancreatitis; Platelet Activating Factor; Reperfusion Injury; Shock, Septic | 1995 |
Cellular and biomolecular mechanisms of liver ischemia and reperfusion injury.
Topics: Animals; Cell Adhesion Molecules; Cytokines; Disease Models, Animal; Endothelium, Vascular; Humans; Ischemia; Liver; Neutrophils; Platelet Activating Factor; Reperfusion Injury | 1994 |
Splanchnic ischaemia/reperfusion and multiple organ failure.
Topics: Animals; Disease Models, Animal; Humans; Inflammation; Interleukin-6; Multiple Organ Failure; Neutrophils; Platelet Activating Factor; Rats; Reperfusion Injury; Splanchnic Circulation | 1996 |
The role of platelet-activating factor antagonists in the prophylaxis of posttransplant acute tubular necrosis.
Topics: Animals; Humans; Kidney; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury | 1996 |
PAF-synthesizing enzymes in neural cells during differentiation and in gerbil brain during ischemia.
Topics: Animals; Brain; Brain Ischemia; Cell Differentiation; Gerbillinae; Humans; Neurons; Platelet Activating Factor; Reperfusion Injury | 1996 |
Primary graft dysfunction after liver transplantation: from pathogenesis to prevention.
Topics: Endothelins; Graft Rejection; Graft Survival; Humans; Kupffer Cells; Leukotrienes; Liver Diseases; Liver Transplantation; Neutrophils; Nitric Oxide; Organ Preservation; Platelet Activating Factor; Reactive Oxygen Species; Reperfusion Injury; Tissue Donors | 1997 |
Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cell Adhesion; Cerebral Hemorrhage; Chemotaxis, Leukocyte; Dextran Sulfate; Dogs; Encephalitis; Endothelium, Vascular; Fibrinolytic Agents; Humans; Integrins; Intercellular Adhesion Molecule-1; Interleukin-1; Mice; Neuroprotective Agents; Neutrophils; Papio; Phagocytosis; Platelet Activating Factor; Rabbits; Rats; Reperfusion Injury; Thrombolytic Therapy; Tumor Necrosis Factor-alpha | 1998 |
Role of platelet-activating factor in cardiovascular pathophysiology.
Topics: Anaphylaxis; Animals; Cardiovascular Diseases; Cells, Cultured; Endothelium, Vascular; Heart; Hemodynamics; Humans; In Vitro Techniques; Microcirculation; Myocardium; Neovascularization, Pathologic; Neovascularization, Physiologic; Organ Specificity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Signal Transduction | 2000 |
Current strategies in lung preservation.
Topics: Animals; Antioxidants; Cold Temperature; Cyclic AMP; Cyclic GMP; Free Radical Scavengers; History, 20th Century; Humans; Lung; Lung Injury; Lung Transplantation; Organ Preservation; Platelet Activating Factor; Reperfusion Injury; Respiration, Artificial; Solutions; Vasodilator Agents | 2000 |
Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury.
Topics: Animals; Blood Platelets; Cytokines; Humans; Inflammation; Leukotrienes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Signal Transduction | 1991 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Injury, Ischemia-Reperfusion
Article | Year |
---|---|
Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation.
Topics: Diterpenes; Double-Blind Method; Ginkgolides; Hemodynamics; Humans; Lactones; Lung Diseases; Lung Transplantation; Oxygen; Platelet Activating Factor; Prospective Studies; Reperfusion Injury | 2001 |
89 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Injury, Ischemia-Reperfusion
Article | Year |
---|---|
[Effect of compatibility of ginkgolide A, ginkgolide B and ginkgolide K].
Topics: Animals; Brain Ischemia; Ginkgolides; Lactones; Platelet Activating Factor; Platelet Aggregation; Rats; Reperfusion Injury | 2018 |
Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.
Topics: Amidines; Animals; Azepines; Biological Assay; Carbamates; Dermis; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Extremities; Inflammation; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Neutrophil Infiltration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propionates; Quinolines; Rabbits; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Reperfusion Injury; Triazoles | 2013 |
Leucocyte and platelet adhesion in different layers of the small bowel during experimental total warm ischaemia and reperfusion.
Topics: Animals; Antibodies, Monoclonal; Blood Flow Velocity; Capillaries; Cell Adhesion; Intercellular Adhesion Molecule-1; Intestine, Small; Leukocytes; Microcirculation; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Pyridinium Compounds; Random Allocation; Rats; Rats, Inbred Lew; Reperfusion; Reperfusion Injury; Tetrahydroisoquinolines; Warm Ischemia | 2008 |
Effects of dexamethasone and Salvia miltiorrhizae on the small intestine and immune organs of rats with severe acute pancreatitis.
Topics: Acute Disease; Animals; Dexamethasone; Drug Evaluation, Preclinical; Interleukin-1beta; Intestinal Mucosa; Intestine, Small; Lymphoid Tissue; Male; Microcirculation; Pancreatitis; Plant Preparations; Platelet Activating Factor; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-2; Reperfusion Injury; Salvia miltiorrhiza; Severity of Illness Index | 2010 |
Protection of carbon monoxide intraperitoneal administration from rat intestine injury induced by lipopolysaccharide.
Topics: Aldehydes; Animals; Blotting, Western; Carbon Monoxide; Flow Cytometry; Intercellular Adhesion Molecule-1; Intestinal Mucosa; Intestines; Lipopolysaccharides; Male; Microscopy; p38 Mitogen-Activated Protein Kinases; Peroxidase; Platelet Activating Factor; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2010 |
In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock.
Topics: Animals; Azepines; Cell Adhesion; Endothelium, Vascular; Fluorescent Dyes; Leukocytes; Lymphocyte Function-Associated Antigen-1; Male; Microcirculation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Resuscitation; Rhodamines; Shock, Hemorrhagic; Triazoles | 2002 |
Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants.
Topics: Animals; Antioxidants; Cell Adhesion; Flavonoids; Free Radicals; Hypoxanthine; Inflammation; Leukocytes; Leukotriene B4; Male; Oxidants; Phenols; Platelet Activating Factor; Polyphenols; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes; Superoxide Dismutase; Superoxides; Time Factors; Xanthine Oxidase | 2003 |
Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apoptosis; Caspase 9; Caspases; Enzyme Activation; Fas Ligand Protein; Interleukin-10; Interleukin-6; Intestinal Mucosa; Intestine, Small; Membrane Glycoproteins; Models, Biological; Phospholipases A; Platelet Activating Factor; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Reperfusion Injury; Signal Transduction | 2003 |
Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Imidazoles; Intestinal Diseases; Intestines; Lung Diseases; Male; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reperfusion Injury | 2003 |
Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats.
Topics: Acetylcysteine; Animals; Cytoprotection; Free Radical Scavengers; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Intestinal Mucosa; Intestines; Ischemia; Leucine; Male; Neutrophil Infiltration; Permeability; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2003 |
Beneficial effects of intraluminal nitroglycerin in intestinal ischemia-reperfusion injury in rats.
Topics: Administration, Topical; Animals; Bile; Hemodynamics; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Models, Animal; Neutrophil Activation; Neutrophil Infiltration; Nitric Oxide; Nitroglycerin; Permeability; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Vasodilator Agents | 2003 |
Antagonisation of platelet activating factor--a new therapeutic concept for improvement of organ quality in lung preservation.
Topics: Animals; Bicarbonates; Blood Pressure; Calcium Chloride; Cardioplegic Solutions; Dogs; Heart; Heart-Lung Transplantation; Lung; Magnesium; Models, Animal; Organ Preservation; Platelet Activating Factor; Potassium Chloride; Reperfusion Injury; Respiratory Function Tests; Sodium Chloride; Vascular Resistance | 1992 |
Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bile; Capillary Permeability; Guinea Pigs; In Vitro Techniques; Infusion Pumps; Liver; Liver Circulation; Liver Diseases; Male; Organ Size; Platelet Activating Factor; Portal Vein; Reperfusion Injury; Thromboxane A2; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2004 |
The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion.
Topics: Acute Disease; Animals; Humans; Interleukin-1; Interleukin-10; Intestines; Ischemia; Kallikrein-Kinin System; Neutrophils; Platelet Activating Factor; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2005 |
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antithrombin III; Extracorporeal Membrane Oxygenation; Fluid Therapy; Free Radical Scavengers; Humans; Lung Diseases; Lung Transplantation; Matrix Metalloproteinases; Nitric Oxide; Platelet Activating Factor; Postoperative Care; Prostaglandins; Pulmonary Surfactants; Receptors, Complement; Reoperation; Reperfusion Injury; Respiration, Artificial | 2005 |
PAF antagonist BN-52021 reduces intercellular adhesion molecule-1 expression and oxidative stress in rats with reperfusion damage due to unilateral testicular torsion.
Topics: Analysis of Variance; Animals; Diterpenes; Fibrinolytic Agents; Ginkgolides; Immunohistochemistry; Intercellular Adhesion Molecule-1; Lactones; Male; Oxidative Stress; Platelet Activating Factor; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spermatic Cord Torsion | 2006 |
Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat.
Topics: Animals; Endothelin Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Fetal Weight; Isoenzymes; Male; Ovary; Phospholipases A; Phospholipases A2; Placenta; Platelet Activating Factor; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Uterus | 2006 |
Acute lung injury in a rat model of intestinal ischemia-reperfusion: the potential time depended role of phospholipases A(2).
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Intestines; Lung; Male; Malondialdehyde; Phospholipases A2; Platelet Activating Factor; Pulmonary Gas Exchange; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Respiratory Distress Syndrome; Time Factors | 2008 |
Platelet-activating factor antagonist TCV-309 protects rat kidneys against ischemia-reperfusion injury.
Topics: Animals; Ischemia; Isoquinolines; Kidney; Kidney Tubules, Proximal; Male; Microvilli; Mitochondrial Swelling; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Lew; Reperfusion Injury; Tetrahydroisoquinolines; Time Factors | 1995 |
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azepines; Bilirubin; Body Weight; Graft Survival; Liver; Liver Function Tests; Liver Transplantation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury; Swine; Time Factors; Triazoles | 1995 |
Spatial heterogeneity of mucosal blood flow during ischemia-reperfusion injury of rat stomach investigated by laser Doppler perfusion imaging.
Topics: Analysis of Variance; Animals; Blood Flow Velocity; Gastric Mucosa; Hemodynamics; Ischemia; Laser-Doppler Flowmetry; Male; Microcirculation; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Reperfusion Injury; Stomach | 1995 |
Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injury.
Topics: Animals; Blood Pressure; Dogs; Female; Heart Rate; Infusions, Intravenous; Models, Cardiovascular; Muscle, Skeletal; Necrosis; Organ Size; Pentoxifylline; Platelet Activating Factor; Reperfusion Injury; Time Factors | 1995 |
Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits.
Topics: Animals; Azepines; Cell Adhesion; Cerebrovascular Disorders; Ischemia; Male; Neutrophils; Platelet Activating Factor; Rabbits; Reperfusion Injury; Spinal Cord; Triazoles | 1995 |
Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation.
Topics: Adenosine; Allopurinol; Animals; Glutathione; Graft Rejection; Insulin; Leukocyte Count; Liver; Liver Transplantation; Microscopy, Electron; Mitochondria, Liver; Organ Preservation Solutions; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Raffinose; Reperfusion Injury; Swine; Tissue Preservation; Transaminases | 1995 |
Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft.
Topics: Animals; Diterpenes; Ginkgolides; L-Lactate Dehydrogenase; Lactones; Liver; Liver Transplantation; Male; Neutrophils; Organ Preservation; Peroxidase; Platelet Activating Factor; Rats; Rats, Wistar; Reperfusion Injury | 1995 |
Donor administration of PAF antagonist (TCV-309) enhances lung preservation.
Topics: Animals; Carbon Dioxide; Dogs; Isoquinolines; Lung; Lung Transplantation; Organ Preservation; Oxygen; Partial Pressure; Peroxidase; Platelet Activating Factor; Pulmonary Artery; Pulmonary Veins; Pyridinium Compounds; Reperfusion; Reperfusion Injury; Tetrahydroisoquinolines | 1995 |
Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Heparin; Hepatectomy; Ketone Bodies; Lactates; Leukocyte Count; Liver Transplantation; Neutrophils; Organ Preservation; Piperidines; Platelet Activating Factor; Platelet Count; Pyridinium Compounds; Random Allocation; Reperfusion Injury; Swine; Time Factors | 1995 |
Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury.
Topics: Animals; Creatinine; Ischemia; Isoquinolines; Kidney; Male; Microscopy, Video; Organ Preservation; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Lew; Reperfusion Injury; Temperature; Tetrahydroisoquinolines | 1995 |
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Ileum; Isoquinolines; Leukocyte Count; Leukocytes; Lung; Male; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Splenic Artery; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha | 1994 |
LTC4/LTB4 alterations in rat forebrain ischemia and reperfusion and effects of AA-861, CV-3988.
Topics: Animals; Benzoquinones; Brain Edema; Brain Ischemia; Injections, Intraperitoneal; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Phospholipid Ethers; Platelet Activating Factor; Premedication; Prosencephalon; Rats; Rats, Wistar; Reperfusion Injury | 1994 |
Leukocytes and the inflammatory response.
Topics: Adhesiveness; Age Factors; Animals; Antibodies, Monoclonal; Antigens, CD; CD11 Antigens; CD18 Antigens; Cell Adhesion Molecules; Cell Movement; Disease Models, Animal; Endothelium; Humans; Infant, Newborn; Inflammation; Interleukin-8; Multiple Organ Failure; Neutrophils; Platelet Activating Factor; Receptors, Leukocyte-Adhesion; Reperfusion Injury; Respiratory Distress Syndrome | 1993 |
Intraoperative increment of platelet-activating factor in clinical liver transplantation.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Child; Child, Preschool; Female; Humans; Infant; Liver Transplantation; Male; Platelet Activating Factor; Reperfusion Injury | 1994 |
Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
Topics: Animals; Azepines; Liver; Liver Circulation; Male; Neutrophils; Oxyhemoglobins; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Triazoles; Vinblastine | 1994 |
Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ.
Topics: Adenosine Triphosphate; Animals; Diterpenes; Endothelium, Vascular; Free Radicals; Ginkgolides; Ischemia; Lactones; Liver; Male; Malondialdehyde; Platelet Activating Factor; Purine-Nucleoside Phosphorylase; Rats; Rats, Wistar; Reperfusion Injury | 1993 |
Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
Topics: Analysis of Variance; Animals; Biological Assay; Creatine Kinase; Isoenzymes; Leukopenia; Macrophages; Male; Myocardial Ischemia; Myocardial Reperfusion; Necrosis; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 1993 |
Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation.
Topics: Animals; Deferoxamine; Diterpenes; Eicosanoids; Ginkgolides; Lactones; Male; Pancreas Transplantation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1994 |
Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model.
Topics: Animals; Creatinine; Disease Models, Animal; Diterpenes; Ginkgolides; Hypertonic Solutions; Infusions, Intravenous; Infusions, Parenteral; Kidney Diseases; Kidney Function Tests; Lactones; Male; Nephrectomy; Plant Extracts; Platelet Activating Factor; Rats; Rats, Wistar; Reperfusion Injury; Sodium | 1993 |
Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Graft Survival; Ischemia; Lactones; Liver Circulation; Liver Transplantation; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Wistar; Reperfusion Injury | 1993 |
Involvement of platelet-activating factor (PAF) in endotoxin- or ischaemia-induced intestinal hyperpermeability in the rat.
Topics: Allopurinol; Animals; Azepines; Endotoxins; Free Radical Scavengers; Intestinal Mucosa; Intestines; Male; Permeability; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Thienopyridines; Triazoles; Xanthine Oxidase | 1993 |
[Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass].
Topics: Animals; Cardiopulmonary Bypass; Dogs; Humans; Leukocyte Count; Lung Diseases; Platelet Activating Factor; Platelet Count; Reperfusion Injury | 1993 |
Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue.
Topics: Animals; Bile; Endotoxins; Epoprostenol; Glutathione; Ischemia; Isoquinolines; Liver; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Reperfusion Injury; Tetrahydroisoquinolines | 1993 |
The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung.
Topics: Animals; Dogs; Ischemia; Isoquinolines; Leukocyte Count; Lung; Lung Compliance; Platelet Activating Factor; Pulmonary Circulation; Pyridinium Compounds; Reperfusion Injury; Tetrahydroisoquinolines; Vascular Resistance | 1993 |
Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
Topics: Animals; Azepines; Capillary Permeability; Hemodynamics; Intestines; Ischemia; Lung; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Triazoles | 1996 |
The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia.
Topics: Animals; Hot Temperature; Immunity, Cellular; Ischemia; Isoquinolines; Kidney; Kidney Cortex; Kidney Transplantation; Lung; Macrophages; Monocytes; Neutrophils; Organ Preservation; Peroxidase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rats; Rats, Inbred Lew; Reperfusion Injury; Tetrahydroisoquinolines; Time Factors | 1996 |
Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion.
Topics: Animals; Aspartate Aminotransferases; Chemokines, CXC; Chemotactic Factors; Cytokines; Growth Substances; Intercellular Signaling Peptides and Proteins; Liver; Lung; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Wistar; Reperfusion Injury; Superoxides; Tumor Necrosis Factor-alpha | 1996 |
Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Adenine Nucleotides; Ammonia; Analysis of Variance; Animals; Blood Gas Analysis; Blood Glucose; Energy Metabolism; Hydrogen-Ion Concentration; Lactic Acid; Liver; Male; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Pyruvic Acid; Rabbits; Reperfusion Injury; Thromboxane B2 | 1996 |
Platelet-activating factor modulates leukocyte adhesion to endothelium in ischemia-reperfusion.
Topics: Animals; Azepines; Cell Adhesion; Cheek; Cricetinae; Endothelium, Vascular; Leukocytes; Male; Mesocricetus; Mouth Mucosa; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Triazoles | 1996 |
The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
Topics: Animals; Animals, Newborn; Brain; Cerebral Cortex; Corpus Striatum; Diterpenes; Excitatory Amino Acid Agonists; Fibrinolytic Agents; Functional Laterality; Ginkgolides; Hippocampus; Hypoxia, Brain; Ischemic Attack, Transient; Lactones; N-Methylaspartate; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors | 1996 |
Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury.
Topics: Animals; Capillary Permeability; Cheek; Cricetinae; Male; Mesocricetus; Microcirculation; Nitric Oxide; Platelet Activating Factor; Reperfusion Injury | 1996 |
Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
Topics: Animals; Cold Temperature; Diterpenes; Fibrinolytic Agents; Ginkgolides; Glomerular Filtration Rate; Glucose; Humans; Hypertonic Solutions; In Vitro Techniques; Kidney; Lactones; Male; Neutrophils; Organ Preservation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury; Tromethamine; Vascular Resistance | 1997 |
Postural vasoregulation and mediators of reperfusion injury in venous ulceration.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cytokines; Humans; Interleukin-1; Interleukin-6; Ischemia; Laser-Doppler Flowmetry; Leg; Leukotriene B4; Microcirculation; Middle Aged; P-Selectin; Platelet Activating Factor; Plethysmography, Impedance; Posture; Receptors, Interleukin-1; Regional Blood Flow; Reperfusion Injury; Thromboxane B2; Treatment Outcome; Tumor Necrosis Factor-alpha; Varicose Ulcer; Vasomotor System; Wound Healing | 1997 |
Role of platelet-activating factor in skeletal muscle ischemia-reperfusion injury.
Topics: Animals; Azepines; Dogs; Female; Heart Rate; In Vitro Techniques; Ischemia; Muscle, Skeletal; Necrosis; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury; Triazoles | 1996 |
The role of platelet-activating factor in musculocutaneous flap reperfusion injury.
Topics: Animals; Arteries; Biopsy; Carbon Radioisotopes; Female; Furans; Gene Expression; Graft Survival; Immunohistochemistry; Indium Radioisotopes; Injections, Intra-Arterial; Ischemia; Leukocyte Count; Muscle, Skeletal; Neutrophils; Platelet Activating Factor; Radionuclide Imaging; Radiopharmaceuticals; Reperfusion; Reperfusion Injury; Skin Transplantation; Surgical Flaps; Swine | 1997 |
Involvement of platelet-activating factor in cell death induced under ischemia/postischemia-like conditions in an immortalized hippocampal cell line.
Topics: Azepines; Calcium; Cell Death; Cell Line, Transformed; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hippocampus; Ischemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Signal Transduction; Triazoles | 1998 |
The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus.
Topics: Animals; Catalase; Creatine Kinase; Flavonoids; Ginkgo biloba; Ileal Diseases; Ileum; Intestinal Obstruction; Ischemia; Ligation; Lipid Peroxidation; Malondialdehyde; Oxidation-Reduction; Phosphates; Plant Extracts; Platelet Activating Factor; Rats; Reperfusion Injury; Vasodilator Agents | 1998 |
Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
Topics: Animals; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Free Radicals; Incidence; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridines; Reperfusion Injury; Thiazoles; Ventricular Fibrillation | 1998 |
Platelet activating factor antagonism in pure skin flaps exposed to ischaemia-reperfusion injury.
Topics: Animals; Female; Furans; Neutrophil Activation; Peroxidase; Platelet Activating Factor; Reperfusion Injury; Surgical Flaps; Swine | 1999 |
Roles of platelet-activating factor, interleukin-1beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion.
Topics: Animals; Interleukin-1; Interleukin-6; Intestinal Mucosa; Intestines; Ischemia; Male; Mesenteric Arteries; Permeability; Peroxidase; Platelet Activating Factor; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1999 |
Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.
Topics: Animals; Drug Therapy, Combination; Endothelin Receptor Antagonists; Isoquinolines; Lipid Peroxidation; Lung; Lung Transplantation; Male; Oxygen; Peptides, Cyclic; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred F344; Reperfusion Injury; Tetrahydroisoquinolines; Thiobarbituric Acid Reactive Substances | 1999 |
Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF).
Topics: Acetylcholine; Animals; Diterpenes; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Ginkgolides; In Vitro Techniques; Ischemia; Kidney; Lactones; Male; Nitroprusside; Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Vasodilation; Vasodilator Agents | 1999 |
Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats.
Topics: Acute Kidney Injury; Animals; Imidazoles; Ischemia; Kidney; Male; Nephrectomy; Platelet Activating Factor; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Transforming Growth Factor beta | 1999 |
Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts.
Topics: Animals; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Electrocardiography; Flavonoids; Free Radical Scavengers; Ginkgo biloba; Hemodynamics; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Plant Extracts; Plants, Medicinal; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Tacrolimus | 2000 |
The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury.
Topics: Alprostadil; Animals; Female; Histocompatibility Antigens Class II; Inflammation Mediators; Infusions, Intravenous; Isoquinolines; Platelet Activating Factor; Pyridinium Compounds; Regression Analysis; Reperfusion Injury; Swine; T-Lymphocyte Subsets; Tetrahydroisoquinolines; Up-Regulation | 2000 |
Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation.
Topics: Animals; Disease Models, Animal; Drug Interactions; Leukocytes; Liver; Male; Oxidative Stress; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion; Reperfusion Injury; Resuscitation; Shock, Hemorrhagic; Time Factors; Xanthine Oxidase | 2000 |
Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats.
Topics: Animals; Endothelium; Epithelium; Imidazoles; Intestinal Mucosa; Intestines; Leucine; Male; Permeability; Platelet Activating Factor; Premedication; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors | 2000 |
Platelet-activating factor contributes to postischemic vasospasm.
Topics: Animals; Genitalia, Male; Injections, Intra-Arterial; Ischemia; Male; Microcirculation; Muscle, Skeletal; Nitric Oxide; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thromboxane A2; Time Factors; Vasoconstriction | 2000 |
The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion.
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Blood Urea Nitrogen; Creatinine; Endothelin-1; Ischemia; Isoquinolines; Kidney; Liver; Liver Circulation; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Tetrahydroisoquinolines | 2000 |
Platelet activating factor acetylhydrolase decreases lung reperfusion injury.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adenosine; Allopurinol; Animals; Glutathione; Hypertonic Solutions; In Vitro Techniques; Insulin; Lung; Male; Organ Preservation Solutions; Oxidative Stress; Phospholipases A; Platelet Activating Factor; Raffinose; Rats; Rats, Inbred Lew; Reperfusion Injury | 2000 |
Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor.
Topics: Animals; Cold Temperature; Creatinine; Kidney; Kidney Transplantation; Male; Platelet Activating Factor; Rats; Rats, Inbred Lew; Reperfusion Injury; Time Factors | 2000 |
The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
Topics: 4-Aminopyridine; Action Potentials; Animals; Azepines; Diterpenes; Electrophysiology; Fibrinolytic Agents; Ginkgolides; Glyburide; Guinea Pigs; Heart; In Vitro Techniques; Lactones; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Potassium Channel Blockers; Reperfusion Injury; Triazoles | 2000 |
Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.
Topics: Animals; Antibodies, Monoclonal; Imidazoles; Intercellular Adhesion Molecule-1; Intestine, Small; Leucine; Leukocytes; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2001 |
[Effect of calcium overload and platelet activating factor on calcitonin gene related peptide release from lung tissue].
Topics: Animals; Bronchoalveolar Lavage Fluid; Calcitonin Gene-Related Peptide; Calcium; In Vitro Techniques; Intestines; Lung; Male; Platelet Activating Factor; Rats; Rats, Wistar; Reperfusion Injury | 1998 |
The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury.
Topics: Animals; Biomarkers; Male; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Renal Circulation; Reperfusion Injury; Time Factors | 2002 |
Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
Topics: Animals; Endothelium, Vascular; Imidazoles; Interleukin-1; Leucine; Lung; Male; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Failure | 2002 |
Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury.
Topics: Animals; Chemotactic Factors; Chemotaxis, Leukocyte; Complement C5a; Dogs; Immune Sera; Immunochemistry; Interleukin-8; Lymph; Myocardium; Neutrophils; Platelet Activating Factor; Rabbits; Reperfusion Injury; Time Factors | 1992 |
Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion.
Topics: Alanine Transaminase; Allopurinol; Animals; Azepines; Gadolinium; Hepatitis; Ischemia; Leukocytes; Liver; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Triazoles | 1992 |
Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion.
Topics: Animals; Gastric Mucosa; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Vitamin E | 1992 |
Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation.
Topics: Adenosine; Allopurinol; Animals; Deferoxamine; Diterpenes; Dogs; Ginkgolides; Glutathione; Insulin; Lactones; Lung; Lung Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Platelet Activating Factor; Raffinose; Reperfusion Injury; Solutions; Tissue Preservation | 1992 |
Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Diterpenes; Dogs; Ginkgolides; Hemodynamics; Indomethacin; Lactones; Male; Mesenteric Arteries; Mesenteric Veins; Platelet Activating Factor; Prostaglandins; Reperfusion Injury; Shock; Thromboxane B2 | 1991 |
Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion.
Topics: Animals; Diterpenes; Female; Ginkgolides; Intestinal Mucosa; Intestine, Small; Lactones; Microscopy, Electron, Scanning; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury; Superoxide Dismutase | 1991 |
[Mechanism of the formation of ischemic gastric injury induced by oxygen radicals in rats].
Topics: Animals; Free Radicals; Gastric Mucosa; Ischemia; Leukotrienes; Neutrophils; Peroxides; Platelet Activating Factor; Reperfusion Injury; Superoxide Dismutase; Superoxides | 1990 |
Role of oxygen-derived free radicals in the pathogenesis of gastric mucosal lesions in rats.
Topics: Allopurinol; Animals; Burns; Female; Free Radical Scavengers; Free Radicals; Gastric Mucosa; Hyperthermia, Induced; Lipid Peroxidation; Male; Oxygen; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Reperfusion Injury; Shock, Traumatic | 1990 |
[Role of PAF for the formation of gastric mucosal injury induced by ischemia-reinfusion in the rat].
Topics: Animals; Free Radicals; Gastric Mucosa; Male; Neutrophils; Oxygen; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury | 1990 |
Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat.
Topics: Allopurinol; Animals; Dimethyl Sulfoxide; Diterpenes; Female; Free Radicals; Ginkgolides; Intestinal Diseases; Intestinal Mucosa; Ischemia; Lactones; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury; Superoxide Dismutase | 1990 |
Gastric hemodynamic disturbance induced by hemorrhagic shock in rats. Role of platelet-activating factor.
Topics: Animals; Gastric Mucosa; Hemodynamics; Male; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reperfusion Injury; Shock, Hemorrhagic; Time Factors | 1990 |
Role of PAF in ischemia-reperfusion injury in the rat stomach.
Topics: Animals; Luminescent Measurements; Male; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury; Stomach | 1989 |
Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Diltiazem; Diterpenes; Ginkgolides; Heart Function Tests; Lactones; Male; Metoprolol; Myocardial Reperfusion; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury | 1989 |
Pharmacologic modulation of experimental postischemic hepatic function.
Topics: Animals; Bile; Disease Models, Animal; Drug Evaluation, Preclinical; Hot Temperature; Ibuprofen; Ischemia; Liver; Male; Microscopy, Electron; Perfusion; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Reperfusion Injury; Superoxide Dismutase; Transaminases | 1989 |
The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach.
Topics: Allopurinol; Animals; Female; Free Radicals; Gastric Mucosa; Ischemia; Necrosis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Reperfusion Injury; Stomach; Superoxide Dismutase | 1988 |